Patients who are on one systemic immunosuppressive agent for chronic GVHD with a plan to withdraw all systemic IST; hydrocortisone continued for treatment of adrenal insufficiency is not considered a systemic IST
No evidence of malignancy at the time of enrollment
Agree to be evaluated at the transplant center or by local provider every 3 months for 12 months after randomization
Agreement to be contacted by phone or e-mail for health status evaluation for up to 3 years
Signed, informed consent
Other eligibility criteria may apply.
Other exclusion criteria may apply.